Wangzhi Li
Stock Analyst at Ladenburg Thalmann
(2.77)
# 1,744
Out of 4,789 analysts
3
Total ratings
66.67%
Success rate
27.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangzhi Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Initiates: Buy | $23 | $174.58 | -86.83% | 1 | Oct 18, 2017 | |
| LPTX Leap Therapeutics | Initiates: Buy | $180 | $0.29 | +61,691.97% | 1 | Mar 7, 2017 | |
| CLRB Cellectar Biosciences | Initiates: Buy | $270 | $0.29 | +92,365.75% | 1 | Dec 21, 2016 |
Krystal Biotech
Oct 18, 2017
Initiates: Buy
Price Target: $23
Current: $174.58
Upside: -86.83%
Leap Therapeutics
Mar 7, 2017
Initiates: Buy
Price Target: $180
Current: $0.29
Upside: +61,691.97%
Cellectar Biosciences
Dec 21, 2016
Initiates: Buy
Price Target: $270
Current: $0.29
Upside: +92,365.75%